In the BioHarmony Drug Report Database

"Preview" Icon

Ocriplasmin

Jetrea (ocriplasmin) is an enzyme pharmaceutical. Ocriplasmin was first approved as Jetrea on 2013-03-13. It is used to treat retinal diseases in the USA. It has been approved in Europe to treat retinal diseases.

 

Trade Name

 

Jetrea
 

Common Name

 

ocriplasmin
 

ChEMBL ID

 

CHEMBL2095222
 

Indication

 

retinal diseases
 

Drug Class

 

Plasmin proteins and derivatives

Image (chem structure or protein)

Ocriplasmin structure rendering